Peter A Thompson Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Peter A Thompson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter A Thompson. Peter A Thompson is a Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and a Director in ProNAi Therapeutics Inc ($DNAI) and a President and CEO in Trubion Pharmaceuticals, Inc ($TRBN) and a President, CEO & Treasurer in Trubion Pharmaceuticals, Inc ($TRBN) and a Director in Synthorx, Inc. ($THOR) and a Director in Adaptimmune Therapeutics PLC ($ADAP) and a Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and a Director in Corvus Pharmaceuticals, Inc. ($CRVS) and a Director in Decibel Therapeutics, Inc. ($DBTX) and a Director in Silverback Therapeutics, Inc. ($SBTX) and a Director in PMV Pharmaceuticals, Inc. ($PMVP) and a Director in Prevail Therapeutics Inc. ($PRVL) and a Director in Edgewise Therapeutics, Inc. ($EWTX).
Address: 14075 NE 30TH PLACE BELLEVUE 98005 WA
Companies in which Peter A Thompson is an Insider
Adaptimmune Therapeutics PLC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Peter A Thompson: Director
Holdings: 4,902,910 shares
Current Value: $22,210,182
Latest Transaction: Jun 06 2018
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALPINE IMMUNE SCIENCES, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: Director
Holdings: 3,070,955 shares
Current Value: $7,186,035
Latest Transaction: Dec 30 2020
$ALPN Market Capitalization: $36.22M
$ALPN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Corvus Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: Director
Holdings: 8,053,298 shares
Current Value: $111,377,111
Latest Transaction: Feb 19 2021
$CRVS Market Capitalization: $293.59M
$CRVS Previous Close: $13.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Decibel Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: Director
Holdings: 2,732,106 shares
Latest Transaction: Feb 19 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Edgewise Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: Director
Holdings: 13,046,956 shares
Latest Transaction: Mar 31 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PMV Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: Director
Holdings: 475,000 shares
Latest Transaction: Sep 29 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Prevail Therapeutics Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Peter A Thompson: Director
Holdings: 0 shares
Latest Transaction: Jan 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RESPONSE BIOMEDICAL CORP
Industry: SERVICES-TESTING LABORATORIES [8734]
Position of Peter A Thompson: Director
Holdings: 0 shares
Latest Transaction: Dec 01 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sierra Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: Director
Holdings: 1,989,949 shares
Latest Transaction: Jul 21 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Silverback Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: Director
Holdings: 507,423 shares
Latest Transaction: Dec 08 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Synthorx, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: Director
Holdings: 0 shares
Latest Transaction: Jan 24 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Trubion Pharmaceuticals, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: President, CEO & Treasurer, President and CEO
Holdings: 385,419 shares
Latest Transaction: Aug 28 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Peter A Thompson
Sentiment: All, ADAP, ALPN, CRVS, DBTX, EWTX, PMVP, PRVL, RPBIF, SRRA, SBTX, THOR, TRBN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 272,724 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 1,668,350 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 1,301,626 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 1,572,960 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 8,187,100 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Buy | P | 16.00 | 312,500 | 5,000,000 | 13,359,456 | 13 M to 13.4 M (+2.40 %) |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | Thompson Peter A. | Director | Buy | P | 16.00 | 46,875 | 750,000 | 319,599 | 272.7 K to 319.6 K (+17.19 %) |